Cantor Fitzgerald initiated coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Free Report) in a report published on Tuesday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $9.00 price objective on the stock.
Separately, Barclays began coverage on shares of Anteris Technologies Global in a research note on Tuesday. They issued an “overweight” rating and a $22.00 price target for the company.
View Our Latest Stock Report on AVR
Anteris Technologies Global Stock Down 2.1 %
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Featured Articles
- Five stocks we like better than Anteris Technologies Global
- NYSE Stocks Give Investors a Variety of Quality Options
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- What is a Stock Market Index and How Do You Use Them?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
